![](https://uwclinicaltrials.org/wp-content/uploads/2024/07/AI_getty-images-NZkh-V8Plek-unsplash_1200w.png)
13 Jun The Future is Now: Clinical Trials Must Keep Up in the Age of Precision Medicine
By Rohit Nambisan, ACRP
Precision medicine brings about transformational advances in how we treat and prevent disease. As our understanding of biology progresses, we advance our ability to precisely target therapies to individuals with specific variants of broad diseases. The continued evolution of biomarker-driven therapeutics has given rise to unique, novel clinical trial designs that are largely focused on complex rare conditions and indications. This is a level of precision and complexity that is helping us take important steps forward in our ongoing battle against the most vexing clinical needs.
While this development is overwhelmingly positive, especially for patients, it creates unintended challenges. As clinical sciences rapidly progress, the processes and technologies that are used to run trials have not kept pace. As a result, we endanger critical advancements in patient care. Read more…